The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Enbrel (Etanercept) Biosimilar Market Research Report 2024

Global Enbrel (Etanercept) Biosimilar Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1739058

No of Pages : 68

Ask Your Query

Synopsis
Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a biologic fusion protein in the TNF blocker class of medications.

Global Enbrel (Etanercept) Biosimilar market is projected to reach US$ 1707.3 million in 2029, increasing from US$ 1247 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Enbrel (Etanercept) Biosimilar market research.

Key manufacturers engaged in the Enbrel (Etanercept) Biosimilar industry include Samsung Bioepis, Novartis, 3s Bio and Lupin, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Enbrel (Etanercept) Biosimilar were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Enbrel (Etanercept) Biosimilar market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Enbrel (Etanercept) Biosimilar market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Samsung Bioepis
  • Novartis
  • 3s Bio
  • Lupin

Segment by Type

  • Syringe
  • Pen

Segment by Application

  • Hospital
  • Pharmacy
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Enbrel (Etanercept) Biosimilar report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Enbrel (Etanercept) Biosimilar Market Overview
1.1 Product Overview and Scope of Enbrel (Etanercept) Biosimilar
1.2 Enbrel (Etanercept) Biosimilar Segment by Type
1.2.1 Global Enbrel (Etanercept) Biosimilar Market Value Comparison by Type (2023-2029)
1.2.2 Syringe
1.2.3 Pen
1.3 Enbrel (Etanercept) Biosimilar Segment by Application
1.3.1 Global Enbrel (Etanercept) Biosimilar Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Enbrel (Etanercept) Biosimilar Market Size Estimates and Forecasts
1.4.1 Global Enbrel (Etanercept) Biosimilar Revenue 2018-2029
1.4.2 Global Enbrel (Etanercept) Biosimilar Sales 2018-2029
1.4.3 Global Enbrel (Etanercept) Biosimilar Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Enbrel (Etanercept) Biosimilar Market Competition by Manufacturers
2.1 Global Enbrel (Etanercept) Biosimilar Sales Market Share by Manufacturers (2018-2023)
2.2 Global Enbrel (Etanercept) Biosimilar Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Enbrel (Etanercept) Biosimilar Average Price by Manufacturers (2018-2023)
2.4 Global Enbrel (Etanercept) Biosimilar Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Enbrel (Etanercept) Biosimilar, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enbrel (Etanercept) Biosimilar, Product Type & Application
2.7 Enbrel (Etanercept) Biosimilar Market Competitive Situation and Trends
2.7.1 Enbrel (Etanercept) Biosimilar Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Enbrel (Etanercept) Biosimilar Players Market Share by Revenue
2.7.3 Global Enbrel (Etanercept) Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enbrel (Etanercept) Biosimilar Retrospective Market Scenario by Region
3.1 Global Enbrel (Etanercept) Biosimilar Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Enbrel (Etanercept) Biosimilar Global Enbrel (Etanercept) Biosimilar Sales by Region: 2018-2029
3.2.1 Global Enbrel (Etanercept) Biosimilar Sales by Region: 2018-2023
3.2.2 Global Enbrel (Etanercept) Biosimilar Sales by Region: 2024-2029
3.3 Global Enbrel (Etanercept) Biosimilar Global Enbrel (Etanercept) Biosimilar Revenue by Region: 2018-2029
3.3.1 Global Enbrel (Etanercept) Biosimilar Revenue by Region: 2018-2023
3.3.2 Global Enbrel (Etanercept) Biosimilar Revenue by Region: 2024-2029
3.4 North America Enbrel (Etanercept) Biosimilar Market Facts & Figures by Country
3.4.1 North America Enbrel (Etanercept) Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Enbrel (Etanercept) Biosimilar Sales by Country (2018-2029)
3.4.3 North America Enbrel (Etanercept) Biosimilar Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enbrel (Etanercept) Biosimilar Market Facts & Figures by Country
3.5.1 Europe Enbrel (Etanercept) Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Enbrel (Etanercept) Biosimilar Sales by Country (2018-2029)
3.5.3 Europe Enbrel (Etanercept) Biosimilar Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enbrel (Etanercept) Biosimilar Market Facts & Figures by Country
3.6.1 Asia Pacific Enbrel (Etanercept) Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Enbrel (Etanercept) Biosimilar Sales by Country (2018-2029)
3.6.3 Asia Pacific Enbrel (Etanercept) Biosimilar Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Enbrel (Etanercept) Biosimilar Market Facts & Figures by Country
3.7.1 Latin America Enbrel (Etanercept) Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Enbrel (Etanercept) Biosimilar Sales by Country (2018-2029)
3.7.3 Latin America Enbrel (Etanercept) Biosimilar Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Enbrel (Etanercept) Biosimilar Market Facts & Figures by Country
3.8.1 Middle East and Africa Enbrel (Etanercept) Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Enbrel (Etanercept) Biosimilar Sales by Country (2018-2029)
3.8.3 Middle East and Africa Enbrel (Etanercept) Biosimilar Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enbrel (Etanercept) Biosimilar Sales by Type (2018-2029)
4.1.1 Global Enbrel (Etanercept) Biosimilar Sales by Type (2018-2023)
4.1.2 Global Enbrel (Etanercept) Biosimilar Sales by Type (2024-2029)
4.1.3 Global Enbrel (Etanercept) Biosimilar Sales Market Share by Type (2018-2029)
4.2 Global Enbrel (Etanercept) Biosimilar Revenue by Type (2018-2029)
4.2.1 Global Enbrel (Etanercept) Biosimilar Revenue by Type (2018-2023)
4.2.2 Global Enbrel (Etanercept) Biosimilar Revenue by Type (2024-2029)
4.2.3 Global Enbrel (Etanercept) Biosimilar Revenue Market Share by Type (2018-2029)
4.3 Global Enbrel (Etanercept) Biosimilar Price by Type (2018-2029)
5 Segment by Application
5.1 Global Enbrel (Etanercept) Biosimilar Sales by Application (2018-2029)
5.1.1 Global Enbrel (Etanercept) Biosimilar Sales by Application (2018-2023)
5.1.2 Global Enbrel (Etanercept) Biosimilar Sales by Application (2024-2029)
5.1.3 Global Enbrel (Etanercept) Biosimilar Sales Market Share by Application (2018-2029)
5.2 Global Enbrel (Etanercept) Biosimilar Revenue by Application (2018-2029)
5.2.1 Global Enbrel (Etanercept) Biosimilar Revenue by Application (2018-2023)
5.2.2 Global Enbrel (Etanercept) Biosimilar Revenue by Application (2024-2029)
5.2.3 Global Enbrel (Etanercept) Biosimilar Revenue Market Share by Application (2018-2029)
5.3 Global Enbrel (Etanercept) Biosimilar Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Samsung Bioepis
6.1.1 Samsung Bioepis Corporation Information
6.1.2 Samsung Bioepis Description and Business Overview
6.1.3 Samsung Bioepis Enbrel (Etanercept) Biosimilar Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Samsung Bioepis Enbrel (Etanercept) Biosimilar Product Portfolio
6.1.5 Samsung Bioepis Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Enbrel (Etanercept) Biosimilar Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis Enbrel (Etanercept) Biosimilar Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 3s Bio
6.3.1 3s Bio Corporation Information
6.3.2 3s Bio Description and Business Overview
6.3.3 3s Bio Enbrel (Etanercept) Biosimilar Sales, Revenue and Gross Margin (2018-2023)
6.3.4 3s Bio Enbrel (Etanercept) Biosimilar Product Portfolio
6.3.5 3s Bio Recent Developments/Updates
6.4 Lupin
6.4.1 Lupin Corporation Information
6.4.2 Lupin Description and Business Overview
6.4.3 Lupin Enbrel (Etanercept) Biosimilar Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lupin Enbrel (Etanercept) Biosimilar Product Portfolio
6.4.5 Lupin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enbrel (Etanercept) Biosimilar Industry Chain Analysis
7.2 Enbrel (Etanercept) Biosimilar Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enbrel (Etanercept) Biosimilar Production Mode & Process
7.4 Enbrel (Etanercept) Biosimilar Sales and Marketing
7.4.1 Enbrel (Etanercept) Biosimilar Sales Channels
7.4.2 Enbrel (Etanercept) Biosimilar Distributors
7.5 Enbrel (Etanercept) Biosimilar Customers
8 Enbrel (Etanercept) Biosimilar Market Dynamics
8.1 Enbrel (Etanercept) Biosimilar Industry Trends
8.2 Enbrel (Etanercept) Biosimilar Market Drivers
8.3 Enbrel (Etanercept) Biosimilar Market Challenges
8.4 Enbrel (Etanercept) Biosimilar Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock